XNYS
CE
Market cap4.91bUSD
Oct 08, Last price
44.81USD
1D
2.17%
1Q
-4.50%
Jan 2017
-43.09%
IPO
180.06%
Name
Celanese Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Celanese Corporation is a global innovator in technology and specialized materials, developing and marketing high-performance engineered polymers worldwide. The company's operations are structured into three primary business units: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment crafts and supplies custom-engineered polymers vital for diverse applications, including automotive, healthcare, industrial products, and consumer electronics. This division also offers acesulfame potassium, an artificial sweetener used in beverages, confectionery, and dairy products, alongside food preservation components such as potassium sorbate and sorbic acid, which are incorporated into foods, drinks, and personal care items. The Acetate Tow division produces acetate tows and flakes, predominantly utilized in filtration systems. Finally, the Acetyl Chain segment manufactures a comprehensive range of acetyl chemicals, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters. These serve as fundamental building blocks for substances like colorants, paints, adhesives, coatings, and pharmaceuticals, and as organic solvents and intermediates for the pharmaceutical, agricultural, and chemical industries. Additionally, this segment produces vinyl acetate-based emulsions for paints, coatings, adhesives, construction, glass fiber, textiles, and paper, alongside ethylene vinyl acetate (EVA) resins and compounds and low-density polyethylene (LDPE). These latter products are integral to flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting. It also specializes in the production of ultra-high molecular weight polyethylene. Established in 1918, Celanese Corporation is headquartered in Irving, Texas.
Related entities
Subsidiaries (50)
Acetate Luxembourg S.a r.l.
CELANESE
CELANESE (SHANGHAI) INTERNATIONAL TRADING CO., LTD.
Celanese EVA Performance Polymers Partnership
CELANESE FAR EAST LIMITED
CELANESE INTERNATIONAL CORPORATION
CELANESE MAGYARORSZÁG ADMINISZTRATÍV SZOLGÁLTATÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG
CELANESE PRODUCTION NETHERLANDS B.V.
CELANESE SALES IBERICA SL
CELANESE SALES UK LIMITED
CELANESE SERVICES GERMANY GMBH
CELANESE SERVICES UK LIMITED
CELANESE SINGAPORE VAM PTE. LTD.
CELANESE US HOLDINGS LLC
HNA ACQUISITION ULC
PERFORMANCE SPECIALTY PRODUCTS (INDIA) PRIVATE LIMITED
ACETATE HONG KONG HOLDINGS LLC
ACETEX CHIMIE
CELANESE (CHINA) HOLDING CO., LTD.
CELANESE (NANJING) ACETYL DERIVATIVES CO., LTD.
Key people
Chuck Kyrish
Chief Financial Officer, Senior Vice President · since 2023
Todd Elliott
Senior Vice President - Engineered Materials · since 2025
Mark Murray
Senior Vice President - Acetyls · since 2023
Ashley Duffie
Senior Vice President, General Counsel · since 2023
Lead Independent Director · since 2024
Scott Richardson
President, Chief Executive Officer, Director · since 2025
Independent Director · since 2024
Independent Chairman of the Board · since 2025
Independent Director · since 2024
Independent Director · since 2015
Independent Director · since 2016
Jay Ihlenfeld
Independent Director · since 2012
Independent Director · since 2020
Independent Director · since 2022
Independent Director · since 2025
Ganesh Moorthy
Independent Director · since 2023
Independent Director · since 2025
Legal address
C/O CORPORATE CREATIONS NETWORK INC.
1521 CONCORD PIKE
SUITE 201
WILMINGTON, DE 19803
US
1521 CONCORD PIKE
SUITE 201
WILMINGTON, DE 19803
US
Headquarters
222 LAS COLINAS BLVD W
STE 900N
IRVING, TX 75039
US
STE 900N
IRVING, TX 75039
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||